Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell
Doximity, 10x Genomics and Omnicell stand out in the Medical Info Systems sector, leveraging AI, telehealth, and workflow innovations for growth.
Zacks·4d ago
More News
3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes
Medical Info Systems rides AI and telehealth tailwinds, lifting DOCS, TXG and OMCL, but cyber risks and industry underperformance keep optimism in check.
Zacks·4d ago
Tempus AI's Key 2025 Milestones Continue to Gain Industry Attention
TEM hits $1.1B TCV, signs 70+ pharma data deals and posts its first positive adjusted EBITDA in Q3 2025 as adoption accelerates.
Zacks·5d ago
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
DXCM looks poised for growth as CGM demand expands, G7 and One+ adoption accelerates, and strong Q4 results support a hold stance.
Zacks·9d ago
Sumitomo Mitsui Trust Group Inc. Sells 25,054 Shares of Omnicell, Inc. $OMCL
Sumitomo Mitsui Trust Group Inc. decreased its position in Omnicell, Inc. (NASDAQ:OMCL - Free Report) by 1.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·10d ago
CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026
Clover Health posts 53% AEP PPO membership growth, lifts total members to 153,000, and says the momentum positions it for GAAP net income profitability in 2026.
Zacks·10d ago
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
FMS' acquisitions, partnerships and global reach fuel growth, even as rising costs and optimization efforts weigh on near-term performance.
Zacks·10d ago
All You Need to Know About Omnicell (OMCL) Rating Upgrade to Buy
Omnicell (OMCL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·12d ago
OMCL vs. HIMS: Which Stock Is the Better Value Option?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Zacks·12d ago
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the fourth quarter and full year...